Anti-CD40 Antibody Quantification via LC-MS/MS Peptide Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying therapeutic antibodies, such as anti-CD40 antibodies, face challenges with background interference and limitations in sensitivity and selectivity, making it difficult to accurately measure their concentrations in samples.
Innovation Solution
A method involving the extraction of anti-CD40 antibodies or their antigen-binding fragments, followed by digestion with proteases like trypsin and Lys-C, and subsequent detection by mass spectrometry, specifically using liquid chromatography tandem mass spectrometry (LC-MS/MS), to quantify the released analytic peptides, which represents the amount of the antibody.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current assays are used to quantify therapeutic antibodies, then the measurement process is simpler, but the sensitivity and selectivity are insufficient and background interference occurs
Solution Approach 1:
The antibody molecule is segmented into smaller peptide fragments through proteolytic digestion. This segmentation allows the detection system to measure specific peptide sequences (analytic peptides) that are characteristic of the intact antibody, thereby improving sensitivity and selectivity while avoiding the limitations of measuring the whole antibody in complex biological matrices.
Solution Approach 2:
Proteases serve as intermediaries that convert the intact antibody into measurable peptide fragments. This intermediary step transforms the measurement problem from detecting the whole antibody (which suffers from background interference) to detecting specific peptide sequences (which can be measured with high precision by mass spectrometry).
2Measurement precision
If current assay methods are used, then the procedure is less complex, but background interference reduces measurement accuracy
Solution Approach 1:
The method extracts specific analytic peptides from the intact antibody through proteolytic digestion. By taking out and measuring these specific peptide sequences rather than the whole antibody, the method eliminates background interference from other proteins and molecules in the sample, thereby improving measurement accuracy.
Solution Approach 2:
The method replaces traditional immunoassay mechanisms (which rely on antibody-antigen binding and are susceptible to background interference) with mass spectrometry detection of peptide sequences. This substitution provides superior measurement accuracy by directly detecting the molecular mass and fragmentation patterns of the analytic peptides.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the sensitivity and selectivity of antibody quantification, allowing for precise measurement down to 0.5 ng/mL, overcoming the limitations of existing methods.
Implementation Method 1
digesting the extracted anti-CD40 antibody or antigen-binding fragment thereof with a protease to release one or more analytic peptides from the anti-CD40 antibody or antigen-binding fragment thereof
Implementation Method 2
detecting the one or more analytic peptides by mass spectrometry, thereby determining the amount of the anti-CD40 antibody or antigen-binding fragment thereof in the sample
Implementation Method 3
specifically using liquid chromatography tandem mass spectrometry (LC-MS/MS)
Data Source
AI summary
The present disclosure relates to methods of determining the amount of an anti-CD40 antibody in a sample. The present disclosure also relates to anti-CD40 antibody signature analytic peptides.